Pharmaceutical Services

ELIQUENT Life Sciences Announces Strategic Acquisition of Azzur Consulting – Strengthening Full-Service Quality & Compliance Capabilities

ELIQUENT Life Sciences (ELIQUENT), a global regulatory, quality, and safety consulting firm, announces the acquisition of Azzur Consulting, a leading quality and validation engineering firm. This strategic acquisition reinforces ELIQUENT’s position as a premier provider of end-to-end support for every stage of the product lifecycle. With this acquisition, ELIQUENT gains deeper technical delivery capabilities that […]

ELIQUENT Life Sciences Announces Strategic Acquisition of Azzur Consulting – Strengthening Full-Service Quality & Compliance Capabilities Read More »

Tobin Scientific Closes $65M Investment to Accelerate Growth Across Life Sciences Infrastructure

Tobin Scientific, a leading provider of cGMP storage, biorepository services, and specialized logistics for the life sciences industry, announces that it has closed a significant capital raise to support its next phase of growth. Denali Growth Partners and Truck 9 Partners led the minority growth equity investment, and Eastern Bank provided a comprehensive financing package

Tobin Scientific Closes $65M Investment to Accelerate Growth Across Life Sciences Infrastructure Read More »

Charles River Launches Strategic Review and Shakes up Board amid Regulatory Uncertainty, Sliding Revenue

Amid a chaotic biopharma ecosystem and declining revenues, Charles River Laboratories is initiating a strategic review and shaking up its board. The CRO’s board will “conduct a comprehensive strategic review and evaluation of Charles River’s business and prospects,” the company said in a May 7 release, “including an examination of various alternatives to enhance long-term

Charles River Launches Strategic Review and Shakes up Board amid Regulatory Uncertainty, Sliding Revenue Read More »

Flourish Research Continues Expansion with Acquisition of Center for Advanced Research & Education

Flourish Research (“Flourish”), a leading multi-site clinical trial organization focused primarily on cardiovascular, metabolic, neuroscience, and infectious disease therapeutic areas, announces the acquisition of the Center for Advanced Research & Education (“CARE”), a leading multi-therapeutic research facility dedicated to advancing innovation in healthcare through conducting phase I-IV clinical trials. Founded in 1998 by Drs. Chris

Flourish Research Continues Expansion with Acquisition of Center for Advanced Research & Education Read More »

Clario Announces Completion of Acquisition of WCG’s eCOA Business

Clario, a leading provider of digital endpoint data solutions to the clinical trial industry, announces completion of its acquisition of WCG’s electronic clinical outcome assessment (eCOA) business. This strategic move enhances Clario’s ability to provide best-in-class data collection and analysis solutions for neuroscience drug development, reinforcing its commitment to delivering high-quality, reliable data across all

Clario Announces Completion of Acquisition of WCG’s eCOA Business Read More »

Scroll to Top